Table IV.
Drug/surfactant | Solubilization parameters | ||||||||
---|---|---|---|---|---|---|---|---|---|
Water | 0.15 M NaCl | Buffer | |||||||
χ | K | a | χ | K | a | χ | K | a | |
Repaglinide | |||||||||
SDS | 36.77 | 20.90 | −7.53 | 43.64 | 24.80 | −7.96 | – | – | – |
CTAB | 35.18 | 19.99 | −7.42 | 34.45 | 19.58 | −7.37 | 643.23 | 365.53 | −14.62 |
T-80 | 41.58 | 23.63 | −7.84 | 39.65 | 22.53 | −7.72 | 266.80 | 151.61 | −12.44 |
SDS + T-80 | 52.23 | 29.68 | −8.40 | 38.87 | 22.09 | −7.67 | – | – | – |
CTAB + T-80 | 19.74 | 11.22 | −5.99 | 44.42 | 25.24 | −8.00 | 562.91 | 319.88 | −14.29 |
Pioglitazone | |||||||||
SDS | 20.53 | 28.71 | −8.32 | 22.96 | 32.11 | −8.60 | – | – | – |
CTAB | 3.85 | 5.39 | −4.17 | 6.83 | 9.55 | −5.59 | 51.62 | 72.19 | −10.60 |
T-80 | 3.50 | 4.89 | −3.93 | 5.01 | 7.01 | −4.82 | 0.63 | 0.88 | +0.32 |
SDS + T-80 | 28.10 | 39.29 | −9.10 | 358.93 | 501.94 | −15.41 | – | – | – |
CTAB + T-80 | 8.31 | 11.62 | −6.08 | 123.05 | 172.07 | −12.76 | 9.16 | 12.81 | −6.32 |
Rosiglitazone | |||||||||
SDS | 19.03 | 14.69 | −7.53 | 22.99 | 17.75 | −7.96 | – | – | – |
CTAB | 20.33 | 15.69 | −7.42 | 25.19 | 19.45 | −7.37 | 130.68 | 100.87 | −14.62 |
T-80 | 18.38 | 14.19 | −7.84 | 16.28 | 12.56 | −7.72 | 14.13 | 10.91 | −12.44 |
SDS + T-80 | 5.82 | 4.49 | −8.40 | 347.29 | 268.07 | −7.67 | – | – | – |
CTAB + T-80 | 16.51 | 12.75 | −5.99 | 308.63 | 238.22 | −8.00 | 43.00 | 33.19 | −14.29 |
a χ has been expressed as millimoles of drug solubilized per mole surfactant and values are in kilojoules per mole at 298.15 K